Surgery
Volume 148, Issue 3 , Pages 567-572, September 2010

The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine

  • Kishore K. Doddakula, Mch

      Affiliations

    • Department of Cardiac Surgery, University College Cork, Cork University Hospital, Cork, Ireland
    • ,
  • Peter M. Neary, MB

      Affiliations

    • Academic Department of Surgery, University College Cork, Cork University Hospital, Cork, Ireland
    • ,
  • Jiang H. Wang, PhD

      Affiliations

    • Academic Department of Surgery, University College Cork, Cork University Hospital, Cork, Ireland
    • ,
  • Shastri Sookhai, MD, FRCSI

      Affiliations

    • Academic Department of Surgery, University College Cork, Cork University Hospital, Cork, Ireland
    • ,
  • Aongus O'Donnell, MD, FRCSI(CTh)

      Affiliations

    • Department of Cardiac Surgery, University College Cork, Cork University Hospital, Cork, Ireland
    • ,
  • Tom Aherne, MB, FRCSI

      Affiliations

    • Department of Cardiac Surgery, University College Cork, Cork University Hospital, Cork, Ireland
    • ,
  • David J. Bouchier-Hayes, MD, FRCS

      Affiliations

    • Department of Surgery, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland
    • ,
  • Henry P. Redmond, Mch, FRCSI

      Affiliations

    • Academic Department of Surgery, University College Cork, Cork University Hospital, Cork, Ireland
    • Corresponding Author InformationReprint requests: Henry P. Redmond, Mch, FRCSI, Department of Academic Surgery, Cork University Hospital, Wilton, Cork, Ireland.

Accepted 14 January 2010. published online 12 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: The authors are currently engaged in an unrelated, sponsored clinical trial using taurolidine.

PII: S0039-6060(10)00022-X

doi:10.1016/j.surg.2010.01.006

Surgery
Volume 148, Issue 3 , Pages 567-572, September 2010

Article Tools

* Image Usage & Resolution